Evidence map›Paper›PMID 26248851›Full record

Trial reportBMC nephrology2015

Update: Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass.

Joanna Leigh Dunlop, Alain Charles Vandal, Janak Rashme de Zoysa, Ruvin Sampath Gabriel, Imad Adbi Haloob, Christopher John Hood, Philip James Matheson, David Owen Ross McGregor, Kannaiyan Samuel Rabindranath, David John Semple and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC nephrology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Low dialysate sodium levels for chronic haemodialysis.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Guideline
  3. Low dialysate sodium levels for chronic haemodialysis.The Cochrane database of systematic reviews · 2019
    Pooled it
  4. Trial
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Joanna Leigh DunlopAuckland Clinical School, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 93311, Otahuhu, Auckland, 1640, New Zealand. Joanna.Dunlop@middlemore.co.nz.
Alain Charles VandalFaculty of Health and Environmental Sciences, Auckland University of Technology, North Shore Campus, Private Bag 92006, Auckland, 1142, New Zealand. alain.vandal@aut.ac.nz.
Janak Rashme de ZoysaRenal Service, North Shore Hospital, Waitemata District Health Board, Private Bag 93503, Takapuna, Auckland, 0740, New Zealand. Janak.deZoysa@waitematadhb.govt.nz.
Ruvin Sampath GabrielDepartment of Cardiology, Middlemore Hospital, Counties Manukau District Health Board, Private Bag 93311, Otahuhu, Auckland, 1640, New Zealand. ruvin.gabriel@middlemore.co.nz.
Imad Adbi HaloobBathurst Health Service, New South Wales, Australia. ihaloob@gmail.coml.
Christopher John HoodDepartment of Renal Medicine, Middlemore Hospital, Counties Manukau District Health Board, Private Bag 93311, Otahuhu, Auckland, 1640, New Zealand. Chris.Hood@middlemore.co.nz.
Philip James MathesonDepartment of Nephrology, Wellington Hospital, Capital & Coast District Health Board, Private Bag 7902, Wellington South, New Zealand. philip.Matheson@ccdhb.org.nz.
David Owen Ross McGregorDepartment of Nephrology, Christchurch Hospital, Canterbury District Health Board, Private Bag 4710, Christchurch, New Zealand. David.McGregor@cdhb.govt.nz.
Kannaiyan Samuel RabindranathDepartment of Renal Medicine, Waikato Hospital, Waikato District Health Board, Private Bag 3200, Hamilton, 3240, New Zealand. K.Rabindranath@waikatodhb.health.nz.
David John SempleDepartment of Renal Medicine, Auckland City Hospital, Auckland District Health Board, Private Bag 92024, Auckland, Auckland, 0740, New Zealand. DSemple@adhb.govt.nz.
Mark Roger MarshallAuckland Clinical School, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 93311, Otahuhu, Auckland, 1640, New Zealand. mrmarsh@woosh.co.nz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After the publication of our paper Dunlop et al. "Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass", we became aware of further data correlating left ventricular (LV) mass index at baseline and their corresponding mass at 12 months, using cardiac magnetic resonance imaging (MRI) in patients on hemodialysis. The original published sample size for the SoLID trial of 118 was a conservative estimate, calculated using analysis of covariance and a within person Pearson's correlation for LV mass index of 0.75. New data communicated to the SoLID trial group has resulted in re-calcuation of the sample size, based upon a within person Pearson's correlation of 0.8 but otherwise unchanged assumptions. As a result, the SoLID trial will now recruit 96 participants.

Indexed as

Research DesignSample SizeDialysis SolutionsHeart VentriclesHumansMagnetic Resonance ImagingOrgan SizeRenal DialysisSodiumDialysis SolutionsSodium

Identifiers

PMID26248851
PMCPMC4528362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.